Table 1 |
|||||
|
Reference gene expression stability evaluation |
|||||
|
Tissue type |
Gene |
CV (%) |
M |
Mean CV (%) |
Mean M |
|
|
|||||
|
Neuroblastoma |
UBC |
31.84 |
0.740 |
30.89 |
0.703 |
|
SDHA |
27.40 |
0.660 |
|||
|
HPRT1 |
37.11 |
0.736 |
|||
|
GAPDH |
27.21 |
0.675 |
|||
|
Fibroblast |
YHWAZ |
18.19 |
0.408 |
14.81 |
0.365 |
|
HPRT1 |
8.84 |
0.308 |
|||
|
GAPDH |
17.40 |
0.378 |
|||
|
Leukocyte |
B2M |
15.76 |
0.400 |
15.81 |
0.394 |
|
UBC |
15.79 |
0.389 |
|||
|
YWHAZ |
15.89 |
0.393 |
|||
|
Bone marrow |
YWHAZ |
17.77 |
0.383 |
15.47 |
0.372 |
|
UBC |
13.60 |
0.356 |
|||
|
RPL13A |
15.03 |
0.376 |
|||
|
Normal pool |
TBP |
47.51 |
1.099 |
43.73 |
0.925 |
|
HPRT1 |
46.99 |
0.988 |
|||
|
HMBS |
31.16 |
0.849 |
|||
|
SDHA |
49.50 |
0.869 |
|||
|
GAPDH |
43.50 |
0.819 |
|||
|
|
|||||
|
Hellemans et al. Genome Biology 2007 8:R19 doi:10.1186/gb-2007-8-2-r19 |
|||||
